CLINICAL_TRIALS
trial_result
· 2021-01-29
Clinical Trial Update: YF476 and Type II Gastric Carcinoids [Phase 2]
Summary
Phase 2 trial update for YF476 in Zollinger-Ellison Syndrome was terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Trio Medicines Ltd. | Conditions: Zollinger-Ellison Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2021-01-29